Yarbrough Capital’s Bristol-Myers Squibb BMY Stock Holding History

Yarbrough Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-7,400	Closed	-$383K	–	194
2024 Q3	$383K	Hold	7,400	–	–	0.02%	161
2024 Q2	$307K	Hold	7,400	–	–	0.01%	168
2024 Q1	$401K	Hold	7,400	–	–	0.02%	154
2023 Q4	$380K	Hold	7,400	–	–	0.02%	164
2023 Q3	$429K	Hold	7,400	–	–	0.03%	136
2023 Q2	$473K	Hold	7,400	–	–	0.03%	140
2023 Q1	$513K	Hold	7,400	–	–	0.04%	125
2022 Q4	$532K	Hold	7,400	–	–	0.04%	95
2022 Q3	$526K	Hold	7,400	–	–	0.04%	106
2022 Q2	$570K	Hold	7,400	–	–	0.04%	100
2022 Q1	$540K	Hold	7,400	–	–	0.03%	126
2021 Q4	$461K	Buy	+7,400	New	+$434K	0.02%	148

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Yarbrough Capital's BMY Position: Q4 2024 in Review

Yarbrough Capital sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 7,400 shares — an estimated $383K sold.

Yarbrough Capital first reported a position in BMY in Q4 2021 and held it in 12 quarters. The position peaked at $570K in Q2 2022. 2,493 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

Yarbrough Capital reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
Yarbrough Capital sold 7,400 Bristol-Myers Squibb shares in Q4 2024, an estimated $383K.
Yarbrough Capital first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 12 quarters.
Yarbrough Capital's Bristol-Myers Squibb position peaked at $570K in Q2 2022.
2,493 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Yarbrough Capital's 13F filing for Q4 2024, filed 15 Jan 2025.